Top

Tag: EGFR


Regulatory

Guardant Health’s biopsy companion test receives FDA approval

August 10, 2020

Via: medicaldevice-network.com

The US Food and Drug Administration (FDA) has approved Guardant Health’s Guardant360 CDx for tumour mutation profiling in patients with any solid malignant neoplasm (cancerous tumour). The Guardant360 CDx is also approved as a companion diagnostic to identify non-small cell […]